Russian national guidelines on insulin pump therapy and continuous glucose monitoring for diabetes mellitus patients. DRAFT
Marina Vladimirovna Shestakova,
Aleksandr Yuryevich Mayorov, 
Yury Ivanovich Philippov,
Lyudmila Ibragimovna Ibragimova,
Elena Vladimirovna Pekareva,
Dmitry Nikitich Laptev,
Aleksandra Mikhailovna Glazunova
Yury Ivanovich Philippov,
Lyudmila Ibragimovna Ibragimova,
Elena Vladimirovna Pekareva,
Dmitry Nikitich Laptev,
Aleksandra Mikhailovna Glazunova https://doi.org/10.14341/probl201561655-78
Abstract
Insulin pump therapy (continuous subcutaneous insulin infusion, CSII) and continuous glucose monitoring (CGM) are high-tech treatment and diagnostic tools for diabetes patients management which are actively used worldwide. CSII initiation and pump-users supervision became a part of routine clinical practice in Russia along with the CGM. Present project of clinical guidelines is based on international and domestic experience in CSII and CGM for diabetes treatment. Guidelines should ensure uniformity of CGM and CSII usage in Russia by health care professionals and diabetes patients and provide them an international experience to guarantee height performance of the technology. This article contains a preliminary version of the guidelines (draft) prepared for further expert’s discussion and review. The final version of the clinical guidelines will be sent to the Ministry of Health of the Russian Federation for approval.
About the Authors
Marina Vladimirovna Shestakova
Endocrinology Research Centre; Sechenov First Moscow State Medical University
Russian Federation
MD, PhD, Professor
Russian Federation
MD, PhD, Professor
Aleksandr Yuryevich Mayorov
Endocrinology Research Centre; Sechenov First Moscow State Medical University
Russian Federation
MD, PhD
Russian Federation
MD, PhD
Yury Ivanovich Philippov
https://www.researchgate.net/profile/Yury_Philippov3
Endocrinology Research Centre
Russian Federation
MD, Assistance Researcher in Program Education and Therapy Department of Diabetes Institute
Endocrinology Research Centre
Russian Federation
MD, Assistance Researcher in Program Education and Therapy Department of Diabetes Institute
Lyudmila Ibragimovna Ibragimova
Endocrinology Research Centre
Russian Federation
MD, PhD
Russian Federation
MD, PhD
Elena Vladimirovna Pekareva
Endocrinology Research Centre
Russian Federation
MD, PhD
Russian Federation
MD, PhD
Dmitry Nikitich Laptev
Endocrinology Research Centre
Russian Federation
MD, PhD
Russian Federation
MD, PhD
Aleksandra Mikhailovna Glazunova
Endocrinology Research Centre
Russian Federation
MD
Russian Federation
MD
References
1. Boyle ME, Seifert KM, Beer KA, et al. Guidelines for application of continuous subcutaneous insulin infusion (insulin pump) therapy in the perioperative period. J Diabetes Sci Technol. 2012;6(1):184-190. 3320837.
2. Guidelines for Medical Necessity Determination for Ambulatory Infusion Pumps (Insulin Pumps). In: MassHealth, ed. Vol MG-IP2011.
3. Inpatient Guidelines: Insulin Infusion Pump Management. Queensland Health; 2012.
4. JDRF Position Statement on Insulin Pump Therapy. London: JDRF; 2012.
5. Evidence Based Guideline: External Insulin Pumps. North Carolina: Blue Cross and Blue Shield Association; 2013.
6. Medical Necessity Guidelines: Continuous Glucose Monitoring System (CGMS). Tufts Health Plan; 2014.
7. Amod A, Carrihill M, Dave J, et al. Continuous subcutaneous insulin infusion therapy in type 1 diabetes: 2013 clinical guidelines and recommendations from the Association of Clinical Endocrinologists of South Africa (ACE-SA). JEMDSA. 2013;18(1):15-19.
8. Blevins TC, Bode BW, Garg SK, et al. Statement by the American Association of Clinical Endocrinologists consensus panel on continuous glucose monitoring. Endocr Pract. 2010;16(5):730-745. doi: 10.4158/EP.16.5.730.
9. Cook CB, Boyle ME, Cisar NS, et al. Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital setting: Proposed guidelines and outcome measures. Diabetes Educ. 2005;31(6):849-857.
10. Eugster EA, Francis G. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes. Pediatrics. 2006;118(4):e1244-1249. doi: 10.1542/peds.2006-0662.
11. National Institute for Health and Clinical Excellence. Continuous Subcutaneous Insulin Infusion for the Treatment of Diabetes Mellitus. Technology Appraisal Guidance 151 (Review of Technology Appraisal Guidance 57). London: NICE; 2008.
12. Francks R. Insulin pump service guidelines for children and young people. Vol SW/CL0057/SOP/v001: NHS; 2013:1-31.
13. Grunberger G, Bailey TS, Cohen AJ, et al. Statement by the American Association of Clinical Endocrinologists consensus panel on insulin pump management. Endocr Pract. 2010;16(5):746-762. doi: 10.4158/EP.16.5.746.
14. Hammond P, Boardman S, Greenwood R. ABCD position paper on insulin pumps. Practical Diabetes International. 2006;23(9):395-400. doi: 10.1002/pdi.1023.
15. Hammond PJ, Amiel SA, Dayan CM, et al. ABCD position statement on continuous glucose monitoring: use of glucose sensing in outpatient clinical diabetes care. Practical Diabetes International. 2010;27(2):66-68. doi: 10.1002/pdi.1448.
16. Harrell RM, Orzeck EA, American Association of Clinical Endocrinologists S, Member Advocacy C. Coding guidelines for continuous glucose monitoring. Endocr Pract. 2010;16(2):151-154. doi: 10.4158/EP.16.2.151.
17. Klonoff DC, Buckingham B, Christiansen JS, et al. Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline. J Clin Endocr Metab. 2011;96(10):2968-2979. doi: 10.1210/jc.2010-2756.
18. Liebl A, Henrichs HR, Heinemann L, et al. Continuous Glucose Monitoring: Evidence and Consensus Statement for Clinical Use. Journal of Diabetes Science and Technology. 2013;7(2):500-519. doi: 10.1177/193229681300700227.
19. McIntyre L. Insulin Pump Therapy for Type 1 Diabetes. 2013.
20. Morviducci L, Di Flaviani A, Lauria A, et al. Continuous subcutaneous insulin infusion (CSII) in inpatient setting: Unmet needs and the proposal of a csii unit. Diabetes Technology and Therapeutics. 2011;13(10):1071-1074. doi: 10.1089/dia.2011.0056.
21. Mu Y, Yin S, Chinese Medical Practitioners Association E, Metabolism Branch CSoECDS. Insulin pump therapy guidelines for China (July 2010). J Diabetes. 2012;4(2):127-139. doi: 10.1111/j.1753-0407.2011.00174.x.
22. Phillip M, Battelino T, Rodriguez H, et al. Use of Insulin Pump Therapy in the Pediatric Age-Group: Consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2007;30(6):1653-1662. doi: 10.2337/dc07-9922.
23. Rodgers J. Using Insulin Pumps in Diabetes: A Guide for Nurses and Other Health Professionals. 2008:222. http://eu.wiley.com/WileyCDA/WileyTitle/productCd-0470059257.html.
24. Scheiner G, Sobel RJ, Smith DE, et al. Insulin pump therapy guidelines for successful outcomes. Diabetes Educ. 2009;35(2):29S-41S. doi: 10.1177/0145721709333493.
25. Wilmot EG, Choudhary P, Grant P, Hammond P. Insulin pump therapy: a practical guide to optimising glycaemic control. Practical Diabetes. 2014;31(3):121-125a. doi: 10.1002/pdi.1846.
26. Дедов И.И., Петеркова В.А., Кураева Т.Л., и др. Помповая инсулинотерапия сахарного диабета у детей и подростков. Российский консенсус детских эндокринологов. // Проблемы эндокринологии. – 2012. – Т. 58. – №2(выпуск 2) – С. 3-18. [Dedov II, Peterkova VA, Kuraeva TL, et al. A consensus on Insulin pump therapy of diabetes mellitus using in the children and adolescents. Probl Endokrinol (Mosk). 2012;58(2 suppl 2):3-18. (In Russ.)]
27. Radermecker RP, Scheen AJ. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness. Diabetes Metab Res Rev. 2004;20(3):178-188. doi: 10.1002/dmrr.447.
28. Misso ML, Egberts KJ, Page M, et al. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2010(1):CD005103. doi: 10.1002/14651858.CD005103.pub2.
29. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care. 2003;26(4):1079-1087.
30. Дедов И.И., Шестакова М.В., Александров А.А., и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом (5-й выпуск). // Сахарный диабет. – 2011. – Т.14. – №3s – С. 4-72. [Dedov II, Shestakova MV, Aleksandrov AA, et al. Algorithms of Specialized Medical Care for Diabetes Mellitus Patients. Diabetes mellitus. 2011;14(3s):2-72. (In Russ.)] doi: 10.14341/2072-0351-5612.
31. Hanaire-Broutin H, Melki V, Bessieres-Lacombe S, Tauber JP. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes. Diabetes Care. 2000;23(9):1232-1235. doi: 10.2337/diacare.23.9.1232
32. Frias JP, Bode BW, Bailey TS, et al. A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injections. J Diabetes Sci Technol. 2011;5(4):887-893. doi: 10.1177/193229681100500410.
33. Weintrob N, Schechter A, Benzaquen H, et al. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion. Arch Pediatr Adolesc Med. 2004;158(7):677-684. doi: 10.1001/archpedi.158.7.677.
34. Saudek CD, Duckworth WC, Giobbie-Hurder A, et al. Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group. JAMA. 1996;276(16):1322-1327.
35. Alemzadeh R, Palma-Sisto P, Holzum M, et al. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus. Diabetes Technol Ther. 2007;9(4):339-347. doi: 10.1089/dia.2006.0038.
36. Bruttomesso D, Bonomo M, Costa S, et al. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI). Diabetes Metab. 2011;37(5):426-431. doi: 10.1016/j.diabet.2011.02.002.
37. Meade LT, Rushton WE. Optimizing insulin pump therapy: a quality improvement project. Diabetes Educ. 2013;39(6):841-847. doi: 10.1177/0145721713504628.
38. Pickup J. Insulin Pump Therapy and Continuous Glucose Monitoring. Oxford University Press, Incorporated; 2009.
39. Wizemann E, Renner R, Hepp K. Prospective evaluation of a standardized basal rate distribution for CSII in type 1 diabetes over 6 months. Diabetologie und Stoffwechsel. 2001;10:57.
40. Лаптев Д.Н., Филиппов Ю.И., Емельянов А.О., и др. Оптимизация настроек инсулиновых помп у детей и подростков с сахарным диабетом 1 типа с учетом возрастных особенностей. // Сахарный диабет. – 2013. – Т.16. – №3 – С.109-115. [Laptev DN, Philippov YI, Emel'yanov AO, Kuraeva TL. Age-adjustment of insulin pump settings in children and adolescents with type 1 diabetes mellitus. Diabetes Mellitus. 2013;16(3):109-115. (In Russ.)] doi: 10.14341/2072-0351-98.
41. Walsh J, Roberts R, Bailey T. Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels. J Diabetes Sci Technol. 2010;4(5):1174-1181. doi: 10.1177/193229681000400516.
42. Davidson P, Hebblewhite H, Bode B, et al. Statistically based CSII parameters: correction factor, CF (1700 rule), carbohydrate-to-insulin ratio, CIR (2.8 rule), and basal-to-total ratio. Diabetes Technol Ther. 2003;5(5):A237.
43. Davidson P, Hebblewhite H, Steed R, Bode B. Analysis of Guidelines for Basal-Bolus Insulin Dosing: Basal Insulin, Correction Factor, and Carbohydrate-to-Insulin Ratio. Endocr Pract. 2008;14(9):1095-1101. doi: 10.4158/EP.14.9.1095
44. Walsh J, Roberts R. Pumping Insulin: Everything in a Book for Successful Use of an Insulin Pump. Torrey Pines Press; 1994.
45. Schmid V, Hohberg C, Borchert M, et al. Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3. J Diabetes Sci Technol. 2010;4(4):976-982. doi: 10.1177/193229681000400429.
46. Bode BW. Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues-aspart, lispro, and glulisine. Endocr Pract. 2011;17(2):271-280. doi: 10.4158/EP10260.RA.
47. Ибрагимова Л.И., Филиппов Ю.И., Майоров А.Ю. Эффективность обучения и качество жизни у больных сахарным диабетом 1 типа на помповой инсулинотерапии. // Сахарный диабет. – 2012. – Т. 15. – №1 – С. 35-40. [Ibragimova LI, Filippov YI, Mayorov AY. Insulin pump therapy in type 1 diabetes mellitus: education effectiveness and quality of life. Diabetes mellitus. 2012;15(1):35-40.(In Russ.)] doi: 10.14341/2072-0351-5977.
48. Филиппов Ю.И., Пекарева Е.В., Майоров А.Ю. Некоторые аспекты помповой инсулинотерапии и непрерывного мониторирования гликемии в режиме реального времени (ответ на письмо Е.Д. Горбачева). // Сахарный диабет. – 2010. – Т.13. – №4 – С. 119-124. [Filippov YI, Pekareva EV, Mayorov AY. Selected aspects of insulin pump therapy and continuous glucose monitoring in real time ( in relation to the letter of E.D.Gorbachev). Diabetes mellitus. 2010;13(4):119-124. (In Russ.)] doi: 10.14341/2072-0351-6074.
49. Ramchandani N, Arya S, Ten S, Bhandari S. Real-life utilization of real-time continuous glucose monitoring: the complete picture. J Diabetes Sci Technol. 2011;5(4):860-870. doi: 10.1177/193229681100500407.
50. Markowitz JT, Pratt K, Aggarwal J, et al. Psychosocial correlates of continuous glucose monitoring use in youth and adults with type 1 diabetes and parents of youth. Diabetes Technol Ther. 2012;14(6):523-526. doi: 10.1089/dia.2011.0201.
51. Langendam MW, Luijf YM, Hooft L, et al. Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2012;1:CD008101. doi: 10.1002/14651858.CD008101.pub2.
52. Wojciechowski P, Rys P, Lipowska A, et al. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis. Pol Arch Med Wewn. 2011;121(10):333-343.
53. Golden SH, Brown T, Yeh HC, et al. Methods for Insulin Delivery and Glucose Monitoring: Comparative Effectiveness. Rockville (MD)2012.
54. Vazeou A. Continuous blood glucose monitoring in diabetes treatment. Diabetes Res Clin Pract. 2011;93 Suppl 1:S125-S130. doi: 10.1016/S0168-8227(11)70028-6.
55. Slover RH, 2nd. Continuous glucose monitoring in children and adolescents. Curr Diab Rep. 2012;12(5):510-516. doi: 10.1007/s11892-012-0303-6.
56. Mauras N, Fox L, Englert K, Beck RW. Continuous glucose monitoring in type 1 diabetes. Endocrine. 2012. doi: 10.1007/s12020-012-9765-1.
57. Hermanides J, Phillip M, DeVries JH. Current application of continuous glucose monitoring in the treatment of diabetes: pros and cons. Diabetes Care. 2011;34 Suppl 2:S197-201. doi: 10.2337/dc11-s219.
58. Davey RJ, Stevens K, Jones TW, Fournier PA. The effect of short-term use of the Guardian RT continuous glucose monitoring system on fear of hypoglycaemia in patients with type 1 diabetes mellitus. Prim Care Diabetes. 2012;6(1):35-39. doi: 10.1016/j.pcd.2011.09.004.
59. Rubin RR, Borgman SK, Sulik BT. Crossing the technology divide: practical strategies for transitioning patients from multiple daily insulin injections to sensor-augmented pump therapy. Diabetes Educ. 2011;37 Suppl 1:5S-18S; quiz 19S-20S. doi: 10.1177/0145721710391107.
60. Langeland LB, Salvesen O, Selle H, et al. Short-term continuous glucose monitoring: effects on glucose and treatment satisfaction in patients with type 1 diabetes mellitus; a randomized controlled trial. Int J Clin Pract. 2012;66(8):741-747. doi: 10.1111/j.1742-1241.2012.02947.x.
61. Ludwig-Seibold CU, Holder M, Rami B, et al. Continuous glucose monitoring in children, adolescents, and adults with type 1 diabetes mellitus: analysis from the prospective DPV diabetes documentation and quality management system from Germany and Austria. Pediatr Diabetes. 2012;13(1):12-14. doi: 10.1111/j.1399-5448.2011.00835.x.
62. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study G, Beck RW, Hirsch IB, et al. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009;32(8):1378-1383. doi: 10.2337/dc09-0108.
63. Deiss D, Bolinder J, Riveline JP, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006;29(12):2730-2732. doi: 10.2337/dc06-1134.
64. O'Connell MA, Donath S, O'Neal DN, et al. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial. Diabetologia. 2009;52(7):1250-1257. doi: 10.1007/s00125-009-1365-0.
65. Klonoff DC, Buckingham B, Christiansen JS, et al. Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96(10):2968-2979. doi: 10.1210/jc.2010-2756.
66. Szypowska A, Ramotowska A, Dzygalo K, Golicki D. Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials. Eur J Endocrinol. 2012;166(4):567-574. doi: 10.1530/EJE-11-0642.
67. Combs CA. Continuous glucose monitoring and insulin pump therapy for diabetes in pregnancy. Journal of Maternal-Fetal & Neonatal Medicine. 2012;25(10):2025-2027. doi: 10.3109/14767058.2012.670409.
68. Vigersky RA, Fonda SJ, Chellappa M, et al. Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care. 2012;35(1):32-38. doi: 10.2337/dc11-1438.
Review
For citations:
Shestakova M.V., Mayorov A.Yu., Philippov Yu.I., Ibragimova L.I., Pekareva E.V., Laptev D.N., Glazunova A.M. Russian national guidelines on insulin pump therapy and continuous glucose monitoring for diabetes mellitus patients. DRAFT. Problems of Endocrinology. 2015;61(6):55-78. https://doi.org/10.14341/probl201561655-78
Views:
1155
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
